Robert Zeldin

Robert Zeldin

Chief Tech/Sci/R&D Officer chez MEIRAGTX HOLDINGS PLC

Fortune : 544 625 $ au 31/03/2024

61 ans
Health Technology
Consumer Services
Commercial Services

Profil

Robert K.
Zeldin
is currently the Chief Medical Officer at MeiraGTx Holdings Plc.
Prior to this, he worked as the Chief Medical Officer & Executive Vice President at Acceleron Pharma, Inc. from 2018 to 2019, and as the Senior Vice President-Global Clinical Development at Stallergenes SA from 2011 to 2015.
He also held positions as Chief Medical Officer at Ablynx NV, Vice President at Novartis Pharmaceuticals Corp., Medical Officer at the Center for Biologics Evaluation & Research, and Chief Medical Officer at Immunovant, Inc. Zeldin received his undergraduate degree from The Johns Hopkins University and his doctorate from Tufts University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/01/2024 89 724 ( 0,14% ) 544 625 $ 31/03/2024

Postes actifs de Robert Zeldin

SociétésPosteDébut
MEIRAGTX HOLDINGS PLC Chief Tech/Sci/R&D Officer 05/08/2020
Tous les postes actifs de Robert Zeldin

Anciens postes connus de Robert Zeldin

SociétésPosteFin
ACCELERON PHARMA INC. Chief Tech/Sci/R&D Officer 05/04/2019
STALLERGENES Chief Tech/Sci/R&D Officer 01/01/2015
IMMUNOVANT, INC. Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
Voir l'expérience en détail de Robert Zeldin

Formation de Robert Zeldin

The Johns Hopkins University Undergraduate Degree
Tufts University School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Robert Zeldin

Relations

31

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
MEIRAGTX HOLDINGS PLC

Health Technology

IMMUNOVANT, INC.

Health Technology

Entreprise privées5

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Robert Zeldin